In HCC cells, fibronectin type III domain-containing protein 5 (FNDC5), a precursor of irisin, was found to regulate gene expressions involved in lipogenesis, tumorigenesis as well as inflammation, and increased irisin levels might restrict HCC development via inhibiting de novo lipogenesis (42). Here, FNDC5 is linked to hepatocellular carcinoma.